Investir&+

Investir&+ is a Paris-based impact investment firm investing in companies that combine financial returns with measurable social and environmental outcomes, including selected healthcare and well-being businesses focused on access, prevention, and inclusion. The fund operates with a generalist impact thesis rather than a healthcare-specific mandate and writes checks generally in the EUR 500K to EUR 3M range across seed and Series A, often as a co-investor alongside other French and European investors. Healthcare exposure is partial and concentrated in social health, mental health, and care models for vulnerable populations rather than clinical AI or therapeutics. AI focus is undeclared and not a stated thesis. Founders best suited are French or French-speaking European CEOs at seed and Series A in social health, mental health, prevention, or care delivery for underserved populations, with measurable impact metrics and a clear French market path. Founders who do not fit include US-only digital health teams, therapeutics, devices, and consumer wellness businesses without an impact thesis. Geographic preference is France and Francophone Europe. The entry path is warm introduction through a French impact investing operator, a portfolio CEO, or a co-investor at funds like INCO or Phitrust. LinkedIn outreach to a partner with a focused French impact summary is a reasonable secondary option. Expect impact diligence including outcome metrics and beneficiary definitions alongside commercial questions. Best suited as a French regional lead or strong co-investor for impact-aligned healthcare founders.